Medicare Enrolled

Dr. Ariel Grajales-Cruz

Hematology & Oncology · Tampa, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
12902 USF MAGNOLIA DR, Tampa, FL 33612
8137457365
In practice since 2013 (12 years)
NPI: 1871938001 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Grajales-Cruz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Grajales-Cruz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Grajales-Cruz

Dr. Ariel Grajales-Cruz is a hematology & oncology in Tampa, FL, with 12 years in practice. Based on federal Medicare data, Dr. Grajales-Cruz performed 482 Medicare services across 303 unique beneficiaries.

Between the years covered by Open Payments, Dr. Grajales-Cruz received a total of $417,648 from 27 pharmaceutical and/or device companies across 379 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Grajales-Cruz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice▲ 482 Medicare services$ $417,648 industry payments

Medicare Practice Summary

Medicare Utilization ↗
482
Medicare services
Bottom 43% in FL for hematology & oncology
303
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~40 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)242$74$178
Office visit, established patient, complex (40-54 min)88$101$238
New patient office visit, complex (60-74 min)80$138$342
Hospital follow-up visit, moderate complexity72$63$152
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$417,648
Total received (2018-2024)
Avg $59,664/year across 7 years
Top 3% in FL for hematology & oncology
27
Companies
379
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$394,937 (94.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$14,897 (3.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,814 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$246,071
2023
$92,357
2022
$56,148
2021
$16,386
2020
$2,038
2019
$2,449
2018
$2,200

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$275,750
Amgen Inc.
$55,805
PFIZER INC.
$39,848
Janssen Biotech, Inc.
$24,411
Janssen Scientific Affairs, LLC
$10,034
Janssen Pharmaceuticals, Inc
$3,774
E.R. Squibb & Sons, L.L.C.
$1,577
Genentech USA, Inc.
$694
Celgene Corporation
$656
AstraZeneca Pharmaceuticals LP
$605
Lilly USA, LLC
$582
Seattle Genetics, Inc.
$516
Foundation Medicine, Inc.
$510
SANOFI-AVENTIS U.S. LLC
$471
Karyopharm Therapeutics Inc.
$402
Alexion Pharmaceuticals, Inc.
$370
Novartis Pharmaceuticals Corporation
$313
EISAI INC.
$263
Gilead Sciences, Inc.
$235
Astellas Pharma US Inc
$224
Pharmacyclics LLC, An AbbVie Company
$129
Exelixis Inc.
$124
Eisai Inc.
$120
Boehringer Ingelheim Pharmaceuticals, Inc.
$111
BeiGene USA, Inc.
$69
Genentech, Inc.
$38
BOSTON SCIENTIFIC CORPORATION
$18
Top 3 companies account for 88.9% of total payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · BRUKINSA · Blincyto · CALQUENCE · CARVYKTI · CYRAMZA · Cabometyx · DARZALEX · ELITEK · ELREXFIO · ERLEADA · Erleada · FOUNDATIONONE · GENERAL THERAPIES · GILOTRIF · IMBRUVICA · JEVTANA · KYMRIAH · Kyprolis · Lenvima · PROMACTA · Pomalyst · Revlimid · SARCLISA · SOLIQUA 100/33 · SOLIRIS · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · Trodelvy · VERZENIO · XOSPATA · XPOVIO · Zydelig
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for hematology & oncology in FL.

Equivalent to $86,649 per 100 Medicare services performed
Looking for a hematology & oncology in Tampa?
Compare hematology & oncologys in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
106
Per 100K population
7.1
County median income
$75,011
Nearest hospital
TAMPA VA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Grajales-Cruz is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 3%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Grajales-Cruz experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Grajales-Cruz performed 242 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Grajales-Cruz receive payments from pharmaceutical companies?
Yes. Dr. Grajales-Cruz received a total of $417,648 from 27 companies across 379 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Grajales-Cruz's costs compare to other hematology & oncologys in Tampa?
Dr. Grajales-Cruz's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Grajales-Cruz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →